Tuesday, April 15, 2008

Stephen R. Mattarollo1, 4 , Tony Kenna2, Mie Nieda3 and Andrew J. Nicol1

Jeffrey D. Bloss1

(1) Division of Gynecologic Oncology, Ellis Fischel Cancer Center, 115 Business Loop 70 West, 65203 Columbia, MO, USA


Abstract The management of early-stage cervical cancer involves primarily surgery and/or chemoradiotherapy. When the disease spreads beyond the cervix but remains confined to the pelvis and draining lymph node basins, the mainstay of management is chemoradiotherapy. The use of primary systemic chemotherapy is related to the management of disease that has recurred or spread beyond the pelvic radiation fields. Although the optimal chemotherapy regimen remains to be determined, current protocols and the associated research to support their use are discussed in this review. Additionally, the rationale for use of chemoradiotherapy in locally advanced disease is presented.

No comments: